A recent randomized controlled trial comparing intralesional triple combination therapy (triamcinolone acetonide, 5-fluorouracil, and hyaluronidase) with triamcinolone acetonide monotherapy in treating keloids revealed significant differences in treatment efficacy.

Group A (triple combination) demonstrated a remarkable 54.55% improvement in Vancouver Scar Scale scores by the final follow-up, compared to just 36.65% in Group B (triamcinolone).

The study concludes that intralesional triple combination therapy is a superior option for keloid management.

Source: Indian Journal of Dermatology, Venereology and Leprology | [Read Full Story](https://ijdvl.com/efficacy-and-safety-of-intralesional-triple-combination-versus-intralesional-triamcinolone-acetonide-for-the-treatment-of-keloids-a-randomised-controlled-trial/)